The procedure takes 1.5 to 2 h, depending on which drug is to be estimated.
Materials and Methods

Gas Chromatography
Two Pye 104 gas chromatographs equipped with dual-flame ionization detectors were used in conjunction with Honeywell 1 mV recorders. The silanized glass columns, each 213 cm long and 0.4 cm i.d., were packed with either "1% OV-17" (selective phase) or "2% OV-1" (nonselective phase) (Phase Separations Ltd., England). The phases were supported on acid washed and silanized "Diatomite Retention data for a variety of basic drugs are summarized in Table 2 . The retention times of some of the benzodiazepine metabolites likely to be encountered with the parent compound in the blood, and also of a number of commonly prescribed antidepressant drugs, was established.
Aliquots (25 jil) of the mixed drug standard solution (1 mg of each drug per liter of blood) were added to four tubes, each containing 5 ml of blood, and analyzed as described in the procedure. In each analysis the retention times of the drugs extracted from the blood were the same as those of authentic standards when chromatographed on 1%
OV-17 and 2% OV- samples were extracted and chromatographed on the same day and the other four samples were analyzed at intervals of two or three days. This day-to-day and within-run precision of the method (Table 5) , taken in conjunction with the recovery data given in Table 3 Table 4 . Day-to-day and within-run precision were measured by adding either diazepam or nitrazepam to two large control samples of blood, both of which contained medazepam as internal standard. These two samples were each divided into 10 5-ml aliquots containing 1 jig of diazepam (200 Table 5 .
During a six-month period, and using the methods described in the procedure, I performed the preliminary experiments to determine the percentage recovery of medazepam from whole blood and the relative flame ionization responses of diazepam and nitrazepam TMS relative to madazepam.
It can be seen from Tables 3 and 4 that the results obtained during this  time are reproducible, and taken in conjunction with the day-to-day and within-run precision data given in Table 5 show that the accuracy and reproducibili- 
16
UIaus.8 UrnuSs Only about 30% of the nitrazepam was converted to its TMS derivative, and even this was not consistent. No suitable internalstandard was found that could be used in the determination of medazepam. Diazepam could not be used because it is a metabolite of medazepam that is found in the blood (3). and analysis would have to be carried out by using the 2% OV-i column because of the presence of the medazepam metabolite, diazepam, in the blood. The possibility that other drugs with the same retention time on 2% OV-1 as medazepam could be present ( TMS is formed and GLC analysis is carried out on 1% OV-17. If diazepam is also present, it is separated from nitrazepam TMS on 2% OV-i and the relative areas of the peaks give a ratio that can be applied to the combined peak on 1% OV-17, allowing the quantitation of each substance to be carried out.
The column of choice for the analysis of the benzodiazepines is 1% OV-i7 because it has good separation properties for a large number of basic drugs, some of which have been added to blood and taken through the described analytical procedure. None of these were seen to interfere with the quantitation of medazepam, diazepam, and nitrazepam on OV-17 ( 
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